Microfracture with or without collagen scaffold insertion for adults with chondral or osteochondral defects of the knee: the SISMIC RCT and its challenges during and after the COVID-19 pandemic

医学 随机对照试验 大流行 外科 2019年冠状病毒病(COVID-19) 医疗保健 2019-20冠状病毒爆发 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 梅德林 临床试验 物理疗法 医疗保健系统
作者
Michael Richard Whitehouse,Nick Howells,Lucy Dabner,Russell Thirard,Lucy A. Culliford,Elsa M R Marques,Petra Baji,Andrew Judge,Ashley William Blom,Amanda Burston,Catherine Jameson,Chris A. Rogers
出处
期刊:Health Technology Assessment [NIHR Journals Library]
卷期号:30 (62): 1-25
标识
DOI:10.3310/brts2415
摘要

Background: Around 10,000 symptomatic knee articular cartilage injuries requiring repair occur annually in the United Kingdom, mostly in people under 35 years of age. Microfracture surgery aims to restore cartilage. Adding microstructural scaffolds made of collagen may further improve outcomes. Objectives: To evaluate the clinical and cost-effectiveness of microstructural scaffold in patients undergoing microfracture for a symptomatic chondral or osteochondral defect of the knee. Design: Multicentre, parallel two-group, superiority randomised controlled trial with blinding of participants, research staff and clinical care teams not involved in the surgery. Setting: National Health Service hospitals offering arthroscopic chondral surgery. Participants: . Exclusions were: unstable ligamentous injuries or meniscal tears that would not be treated; a knee with defects on the tibial chondral surface, < 50% native meniscal volume or requiring realignment surgery/osteotomy; and a lesion previously treated with microfracture. Interventions: Lesions were debrided, and microfracture was performed on the exposed subchondral bone. Intervention: microfracture of the chondral or osteochondral lesion with insertion of a bilayer collagen matrix microstructural scaffold, fixed with stiches or fibrin glue. Comparator: microfracture alone. Postoperative physiotherapy was standardised. Participants were randomised 1 : 1 between intervention and control. Main outcome measures: Primary outcome was the Knee Injury and Osteoarthritis Outcome Score at 24 months post randomisation. Secondary outcomes included International Knee Documentation Committee knee evaluation score; Tegner-Lysholm activity grading scale; EuroQol-5 Dimensions, five-level version; Work Productivity and Activity Impairment; complications and resource use measured at 3, 6, 12 and 24 months. Results: Twenty-two patients were screened across 8 sites, 20 of whom were eligible on screening. Of the 20 patients considered initially eligible, 2 patients were not interested and 1 opted for chondroplasty; the remaining 17 all consented to participate. Between November 2021 and October 2022, 10 participants were randomised, 5 to microfracture and 5 to microfracture with scaffold. Three patients failed the final in-surgery eligibility check (lesions had healed), one decided not to have surgery and three were still waiting when the study was closed. The median age was 38 years, and four participants were female. Most participants (seven) had damage to the lateral femoral condyle, and six had a medial and/or lateral meniscal tear. All participants received the allocated treatment and are included in the reported results. When a scaffold was used, the surgery took on average 10 minutes longer. There were three serious adverse events, knee pain and swelling in one participant, and a suspected anaphylactic reaction in another. Limitations: The SISMIC randomised controlled trial did not progress beyond the internal pilot phase due to insufficient recruitment. The target number of sites were opened, but recruitment was only 42% of the target 24 participants randomised. Insufficient data were collected to answer the research question. Conclusions: The SISMIC randomised controlled trial was severely impacted by the COVID-19 pandemic, the limited resources available at sites and the reduced elective orthopaedic surgical activity. Future work: To reflect contemporary practice, we recommend that a future trial evaluates three treatments: chondroplasty, chondroplasty with a microstructural scaffold and autologous chondrocyte implantation. Funding: This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR127849.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
aa完成签到,获得积分10
1秒前
菠菜的应助被Mzuser采纳,获得10
2秒前
脑洞疼的应助被Sheep采纳,获得10
2秒前
英姑的应助被热心向日葵采纳,获得10
3秒前
wenhao发布了新的文献求助10
3秒前
3秒前
脑洞疼的应助被山山而川采纳,获得10
3秒前
柚C美式发布了新的文献求助10
4秒前
机灵的鸣凤完成签到,获得积分10
4秒前
打打的应助被王壬采纳,获得10
4秒前
4秒前
徐文浩完成签到,获得积分20
4秒前
略略略略略完成签到 ,获得积分10
5秒前
cy关闭了cy的文献求助
5秒前
小犁牛完成签到 ,获得积分10
6秒前
贺知什么书完成签到,获得积分10
7秒前
wanci的应助被zzz采纳,获得10
8秒前
爱吃果冻完成签到 ,获得积分10
8秒前
李爱国的应助被ranran采纳,获得50
8秒前
9秒前
MZH完成签到 ,获得积分10
9秒前
芒果加冰完成签到,获得积分10
10秒前
wenhao完成签到,获得积分10
10秒前
10秒前
11秒前
Brufo完成签到,获得积分10
11秒前
研友_VZG7GZ的应助被jom采纳,获得10
11秒前
123发布了新的文献求助10
11秒前
ecauscibe完成签到,获得积分10
11秒前
zz关注了科研通微信公众号
12秒前
希望天下0贩的0的应助被LL采纳,获得10
12秒前
12秒前
13秒前
风吹麦浪的应助被hbchenlibing采纳,获得10
13秒前
13秒前
怡春院李老鸨的应助被Ziqi采纳,获得100
13秒前
桐桐的应助被是真的宇航员啊采纳,获得10
14秒前
14秒前
小狗发布了新的文献求助10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163643
求助须知:如何正确求助?哪些是违规求助? 9557771
关于积分的说明 21741795
捐赠科研通 7754289
什么是DOI,文献DOI怎么找? 3428316
关于科研通互助平台的介绍 2552989
邀请新用户注册赠送积分活动 2472943